On September 6, 2024, JAGSNPHARM witnessed a significant block trade during Session 1, with 22,00,000 shares exchanging hands at a steady price of ₹400.00. Despite the large transaction, the stock closed slightly lower at ₹403.90, registering a decline of 0.97% by the end of the session.
The total value of the trade reached ₹88 crores, highlighting substantial investor interest in the stock. The trading session showed consistency with the stock’s open, high, low, and last traded price (LTP) all at ₹400.00, before closing slightly higher.
This block trade signifies strong liquidity in JAGSNPHARM, possibly indicating strategic investor moves in the pharmaceutical company.
